Home > Constellation EZH2 inhibitor

molecules of the month

Constellation EZH2 inhibitor

long-residence time EZH2 inhibitor

oral efficacy in xenograft model

from optimatization of prior EZH2 inhibitor

"ACS Med. Chem. Lett., Mar. 26, 2020

Constellation Pharma., Cambridge, MA

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.